Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PPTA | DRH |
|---|---|---|
| Price | $20.33 | $12.42 |
| Change today | ▼ 0.25% | ▼ 1.19% |
| Market cap | $2.54B | $2.54B |
| Return, 3 months | +1.7% | +6.6% |
| Return, year to date | -16.0% | +42.2% |
| Return, 1 year | -13.8% | +64.3% |
| P/E (TTM) | -9.9 | 17.3 |
| P/B | 3.5 | 1.7 |
| P/E percentile vs own 5y | 54th | 21st |
| Dividend yield | – | 2.74% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +89.4% | +11.0% |
| Analyst buy share | 100% | 29% |
| RSI (14) | 33 | 54 |
| 30-day volatility | 50.3% | 19.8% |
| Max drawdown, 1 year | -54.6% | -10.8% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
